INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,486,000 | -4.5% | 26,551 | +129.0% | 0.05% | -58.1% |
| Q3 2021 | $1,556,000 | +55.1% | 11,596 | -7.2% | 0.12% | +34.8% |
| Q1 2021 | $1,003,000 | +12.7% | 12,493 | -72.1% | 0.09% | +61.4% |
| Q3 2020 | $890,000 | +21.4% | 44,753 | +28.3% | 0.06% | +11.8% |
| Q2 2020 | $733,000 | +134.9% | 34,882 | +36.8% | 0.05% | +121.7% |
| Q1 2020 | $312,000 | +42.5% | 25,501 | +70.7% | 0.02% | +76.9% |
| Q4 2019 | $219,000 | +31.9% | 14,940 | +20.0% | 0.01% | -7.1% |
| Q3 2019 | $166,000 | -10.8% | 12,450 | +9.6% | 0.01% | -17.6% |
| Q2 2019 | $186,000 | -66.5% | 11,357 | -44.1% | 0.02% | -55.3% |
| Q2 2018 | $555,000 | – | 20,301 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |